PHARMCHEM LABORATORIES INC
10-Q, EX-10.43, 2000-11-13
MEDICAL LABORATORIES
Previous: PHARMCHEM LABORATORIES INC, 10-Q, 2000-11-13
Next: PHARMCHEM LABORATORIES INC, 10-Q, EX-10.44, 2000-11-13



<PAGE>   1

                    MODIFICATION TO LOAN & SECURITY AGREEMENT

     This Modification to that certain Amended and Restated Loan and Security
Agreement (this "Modification") is entered into by and between PHARMCHEM, INC.,
a Delaware corporation ("Borrower") and COMERICA BANK-CALIFORNIA ("Bank") as of
this 7th day of September, 2000.

                                    RECITALS

     A.   Bank and PharmChem Laboratories, Inc. ("Laboratories"),
predecessor-in-interest to Borrower did previously enter into that certain
Amended And Restated Loan and Security Agreement dated as of May 15, 2000
(originally dated as of May 25, 2000 and revised thereafter to be effective as
of the date set forth above) (the "Agreement").

     B.   Thereafter, pursuant to that certain Assumption Agreement made as of
July 27, 2000 between Borrower and Bank, Borrower, as Assignee, assumed all of
the Obligations of Laboratories under the Loan Documents.

     C.   Borrower has requested and Bank has agreed to provide additional
financing to Borrower and to modify the terms of the Loan Documents all as more
specifically set forth below.

     NOW, THEREFORE, for valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, the parties hereto agree as follows:

                                    AGREEMENT

     1.   Incorporation by Reference. The foregoing recitals of facts and
understandings of the parties, and the Agreement as modified hereby, are
incorporated herein by this reference:

     2.   New Loan. Upon the effectiveness of this Modification, Bank shall make
a new loan to Borrower in the principal amount of One Million, Six Hundred
Seventy Three Thousand Eight Hundred Dollars ($1,673,800), the proceeds of which
shall be used by Borrower to repay the principal outstanding under the Term Loan
and for the acquisition of specific equipment. The new loan shall be evidenced
by a Variable Rate-Installment Note which will mature on April 14, 2004 and
which shall be repaid in accordance with the terms set forth therein (the "New
Term Note"). All references to the Term Loan in the Agreement, shall mean the
loan as evidenced by the New Term Note.

     3.   Modification of Agreement.

          a.   Section 1. Definitions and Construction is hereby modified to
define Term Loan, as follows:

               "Term Loan" means the term loan in the amount of One Million Six
          Hundred Seventy Three Thousand, Eight Hundred Dollars ($1,673,800)
          pursuant to the provisions of Section 2.1.2"

          b.   Section 2.1.2 Term Loan is hereby deleted in its entirety, and
replaced with the following:

               "2.1.2 Term Loan

               Bank shall make a Term Loan to Borrower in the aggregate amount
          of One Million Six Hundred Seventy Three Thousand Eight Hundred
          Dollars ($1,673,800). Effective as of the date of the funding thereof,
          the Term Loan shall bear interest at a per annum rate equal to the
          Prime Rate plus one-half of one percent (0.50%). The Term Loan shall
          be payable in monthly installments of principal in the amount of
          Thirty Eight Thousand, Forty Dollars and 91/100 ($38,040.91) each,
          plus all accrued interest, beginning on October 14, 2000 and
          continuing on the same day of each month thereafter through the Term
          Maturity Date, at which time all amounts due under this Section 2.1.2
          and any other amounts owing under this Agreement shall be immediately
          due and payable."

     4.   Conditions to Effectiveness. This Modification shall be effective when
the following conditions have been satisfied:

          (a)  There shall have been delivered to Bank, each of the following,
duly executed and in form satisfactory to Bank:

               (i)   this Modification;

               (ii)  the New Note;

<PAGE>   2

               (iii) a Borrower's Authorization;

               (iv)  an Automatic Loan Payment Authorization;

               (v)   a Borrower's Telephone and Facsimile Authorization;

               (vi)  an Agreement to Furnish Insurance (naming Borrower as the
                     "Named Insured" and Bank as "Loss Payee"), and

               (vii) any other documents or instruments as may be required by
                     Bank to effectuate this Modification.

     5.   Legal Effect. Except as specifically set forth in this Modification
and the New Note, all of the terms and conditions of the Agreement and the Loan
Documents shall remain in full force and effect. All capitalized terms not
otherwise defined herein, shall have the meaning given to them in the Agreement.

     6.   Integration. This is an integrated Modification and supersedes all
prior negotiations and agreements regarding the subject matter hereof. All
amendments hereto must be in writing and signed by the parties.

     7.   Counterparts. This Modification may be executed in any number of
counterparts and by different parties on separate counterparts, each of which,
when executed and delivered, shall be deemed to be an original, and all of
which, when taken together, shall constitute but one and the same Modification.

     IN WITNESS WHEREOF, the parties have agreed as of the date first set forth
above.

"BORROWER"                              "BANK"

PHARMCHEM, INC.                         COMERICA BANK-CALIFORNIA



By /s/ David A. Lattanzio               By /s/ James L. Weber
  ------------------------------------    --------------------------------------
  David A. Lattanzio                      James L. Weber

Title: Vice President & CFO             Title: Vice President



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission